1. Home
  2. GFAI vs IMNN Comparison

GFAI vs IMNN Comparison

Compare GFAI & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.46

Market Cap

13.1M

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.01

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFAI
IMNN
Founded
2018
1982
Country
Singapore
United States
Employees
1698
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
11.5M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
GFAI
IMNN
Price
$0.46
$3.01
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$4.50
N/A
AVG Volume (30 Days)
197.6K
68.1K
Earning Date
04-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.66
N/A
Revenue Next Year
$4.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.37
52 Week High
$1.50
$9.32

Technical Indicators

Market Signals
Indicator
GFAI
IMNN
Relative Strength Index (RSI) 45.75 45.04
Support Level $0.39 $2.52
Resistance Level $0.70 $3.24
Average True Range (ATR) 0.03 0.23
MACD 0.00 0.02
Stochastic Oscillator 52.57 61.11

Price Performance

Historical Comparison
GFAI
IMNN

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: